Dr. Eric Diner, M.D.
What this data tells you about Dr. Diner
Dr. Eric Diner is an urology physician in St. Petersburg, FL, with 19 years in practice. Based on federal Medicare data, Dr. Diner performed 21,256 Medicare services across 1,711 unique beneficiaries.
Between the years covered by Open Payments, Dr. Diner received a total of $9,016 from 47 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Diner is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection | 18,800 | $0 | $0 |
| Office visit, established patient (30-39 min) | 656 | $89 | $311 |
| Office visit, established patient (20-29 min) | 582 | $60 | $221 |
| Bladder ultrasound after voiding | 172 | $8 | $25 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 139 | $136 | $338 |
| Diagnostic exam of bladder and urethra using an endoscope | 134 | $177 | $577 |
| Hospital follow-up visit, moderate complexity | 116 | $62 | $181 |
| New patient office visit (45-59 min) | 102 | $115 | $409 |
| Initial hospital admission, moderate complexity | 93 | $99 | $433 |
| Drug injection, under skin or into muscle | 87 | $10 | $35 |
| Office visit, established patient (10-19 min) | 62 | $42 | $162 |
| Instillation of anti-cancer drug into bladder | 32 | $68 | $213 |
| Limited ultrasound scan of pelvis | 24 | $36 | $118 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 24 | $17 | $162 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 23 | $50 | $174 |
| Biopsy of prostate gland | 22 | $172 | $589 |
| Testosterone undecanoate injection (Aveed) | 22 | $1 | $3 |
| Insertion of stent in ureter using an endoscope | 21 | $101 | $438 |
| Ultrasonic guidance for needle placement | 21 | $45 | $141 |
| Imaging of urinary tract following injection of a contrast agent | 19 | $19 | $68 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 18 | $248 | $772 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 18 | $66 | $433 |
| Office visit, established patient, complex (40-54 min) | 17 | $138 | $435 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 16 | $338 | $1,056 |
| Insertion of tube into ureter using an endoscope through bladder area | 13 | $95 | $325 |
| Hospital follow-up visit, high complexity | 12 | $92 | $257 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 11 | $567 | $1,860 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (67%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Diner is a mixed practice specialist, with above-average Medicare volume (top 5% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Diner experienced with testosterone injection?
Does Dr. Diner receive payments from pharmaceutical companies?
How do Dr. Diner's costs compare to other urology physicians in St. Petersburg?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology